Abstract Gentamicin (GNT) is an aminoglycoside antibiotic used for treatment of serious infections, and the nephrotoxic adverse effect is one of the main therapeutic limitations. This study aimed to investigate the possible protective effect of apocynin (APO) on nephrotoxicity induced by GNT in rats. Twenty-four rats were allocated into three groups: control, GNT (100 mg/kg, intraperitoneally (i.p.)), and GNT plus APO (10 mg/ kg, i.p.). All rats were killed at the end of the experiment, and then the blood, urine, and kidneys samples were taken. GNT-induced nephrotoxicity was manifested by a significant (p < 0.05) increase in the weight of kidney, 24-h urine volume, renal somatic index (RSI), protein in urine, serum lactate dehydrogenase (LDH), creatinine (Cr), blood urea nitrogen (BUN), renal Fas ligand (CD95), nitric oxide (NO), and malondialdehyde (MDA). Furthermore, a significant reduction in body weight, creatinine clearance (CCr), serum albumin, renal superoxide dismutase (SOD), and glutathione activities were detected when compared with the control rats. APO ameliorated the nephrotoxic effect and oxidative damage caused by GNT by improving tissue morphology and significantly decreasing 24-h urine volume, RSI, serum Cr, LDH and BUN, protein in urine, and renal content of MDA, CD95, and NO. Additionally, APO caused a significant elevation in renal SOD activity and CCr when compared with the GNT group. These results confirm that APO by its anti-inflammatory, antiapoptotic, and antioxidant effects can ameliorate GNT-induced nephrotoxicity.
Introduction
Gentamicin (GNT) is an aminoglycoside antibiotic used for the treatment of serious gram-positive and gram-negative bacterial infections. 1 Although it is a powerful antibacterial agent, the nephrotoxic adverse effect is one of the main therapeutic limitations. 2 The nephrotoxicity induced by GNT is a complex situation involving different pathways, such as the reduction of renal blood flow, oxidative stress, inflammation, nitric oxide (NO) generation, 3 lipid peroxidation, the nuclear factor B pathway, 4 apoptosis, 5 and the reduction of efficiency of kidney antioxidant enzymes such as superoxide dismutase (SOD), catalase, glutathione peroxidase, and reduced glutathione (GSH). 6 The administration of compounds with anti-inflammatory, antiapoptotic, or antioxidant activity has been successfully used to block GNT nephrotoxicity. 7, 8 effects on pro-inflammatory cytokines 12 and apoptosis pathway. 13, 14 APO has shown potential therapeutic effects in many diseases by its NOX inhibition, such as diabetic nephropathy, 15 nephrotoxicity induced by cyclosporine, 16 ALI, 17 arteriosclerosis, 18 and arthritis. 19 APO has been used as one of the most promising drugs in experimental models of inflammatory and neurodegenerative diseases but its effect on nephrotoxicity induced by GNT has not been reported.
In the light of the aforementioned information, the hypothesis was made that APO, by its NOX inhibition, could attenuate GNT-induced renal damage and this was investigated by measuring kidney biochemical parameters, oxidative stress biomarkers, and histological examination of the renal tissues.
Materials and methods

Drugs and chemicals
APO was purchased from Sigma-Aldrich Chemical Co. (St. Louis, Missouri, USA), which was kindly provided by Dr Mohammed S El-Awady. GNT as pharmaceutical ampoules (80 mg) preparation was purchased from Alexandria Chemical Co., Egypt.
Experimental animals
Twenty-four adult male Wistar rats, weighing 200 + 20 g with average age of 6-8 weeks, were purchased from "Egyptian Organization for Biological Products and Vaccines," Giza, Egypt. All the procedures and care administered to the animals have been approved by the "Research Ethics Committee" of the Faculty of Pharmacy, Mansoura University, Egypt, which is in accordance with the "Principles of Laboratory Animal Care" (NIH publication no. 85-23, revised 1985).
Experimental protocol
The animals were allocated into the following three groups each consisting of eight rats: (1) in control group, rats did not receive any drug or solvent; (2) in GNT group, for 7 successive days, rats were injected by GNT (100 mg/kg, intraperitoneally (i.p.)) 20 ; (3) in APO/GNT group, APO (10 mg/kg, i.p.) 11 was administrated to rats starting 7 consecutive days before GNT (100 mg/kg, i.p.) injection and another 7 days together with GNT injection.
For a collection of 24-h urine samples, after the last dose (without prior adaptation), animals were immediately kept in individual metabolic cages. These samples were centrifuged for 15 min at 1000 Â g/4
C and kept at À80 C until analyzed. After collection of the urine samples, all the rats were anesthetized with diethyl ether. Blood was collected in tubes from the retro-orbital venous plexus; blood was allowed to clot for 60 min at 25 C. The serum samples were obtained by centrifuging blood at 1000 Â g for 15 min using a cooling centrifuge and stored frozen for biochemical assays.
After collection of the blood samples, the animals were sacrificed by cervical dislocation. The kidneys were immediately removed, rinsed with ice-cold normal saline, blotted with a piece of filter paper, and weighed for calculation of the renal somatic index (RSI). RSI ¼ (the weight of kidney (g)) O (the final weight of the body (g)) Â 100. The left kidneys (50 mg) were used for detection of CD95 (apoptosis) by the flow cytometric method. The remaining part of left kidneys was homogenized in phosphate buffer (0.1 M, pH 7.4) as 10% (w/v). The homogenates were centrifuged for 15 min at 2000 Â g/4 C, and the supernatant was used for biochemical assays. The right kidneys were cleaned and fixed in 10% buffered formalin for histopathological examination.
Biochemical measurements Biochemical measurements in the serum
Serum creatinine (Cr) and blood urea nitrogen (BUN) level were determined according to Bartels et al. 21 and Fawcett and Scott, 22 respectively. Serum Cr and BUN were spectrophotometrically measured at 550 nm and expressed as milligrams per deciliter (mg/dl). In addition, lactate dehydrogenase (LDH) activity and albumin level were assessed according to the method of Henry et al. 23 and Doumas et al., 24 respectively, and expressed as a unit per liter and grams per deciliter, respectively.
Biochemical measurements in urine
Urine (Cr) and protein levels were measured according to Bartels et al. 21 and Daughaday et al., 25 respectively, and expressed as milligrams per deciliter and milligrams per day, respectively.
Creatinine clearance (CCr) was used to determine the glomerular filtration, calculated using the formula "CCr ¼ Cr in urine (mg/dl) Â urine flow (ml/min)/Cr in serum (mg/dl)." Urine flow was calculated by dividing urine volume of 24 h by 1440 (the number of minutes in day) and expressed in milliliters per minute.
Biochemical measurements in kidney tissue homogenate
Biomarkers of oxidative stress including thiobarbituric acid reactive substances (TBARS) levels, GSH, and the activities of SOD were determined in kidney homogenate according to the method of Ohkawa et al., 26 Ellman, 27 
Flow cytometry detection of apoptosis
CD95 as a marker for apoptosis was detected according to Cifone et al. 29 by following the manufacturers instruction of fluorescein isothiocyanate antihuman Fas (CD95) assay kit (BD Biosciences, California, USA), catalog no/size (555673/100 test). Flow cytometry data was analyzed by flow cytometry (FACS [fluorescence-activated cell sorting] caliber flow cytometer; Becton Dickinson, Sunnyvale, California, USA) with a compact air cooked low power 15-m watt argon ion laser beam (488 nm) at the Mansoura Children Hospital. The average number of evaluated nuclei per specimen 20,000 and the number of nuclei scanned were 120 per second using propidium iodide. 30 
Histological examinations
At the end of the experiment, the right kidney was rapidly dissected out, fixed in 10% buffered formalin, then embedded in paraffin, and prepared as (5-mm thick) sections stained with hematoxylin and eosin (H&E). The pathologist doing histopathological assessment was blinded to the protocol of work.
Statistical analysis
Data are expressed as mean + standard error of the mean, where n ¼ number of rats. Statistical analysis was carried out using one-way analysis of variance followed by Tukey-Kramer multiple comparisons post hoc test. The level of significance was set at p < 0.05. GraphPad Prism V 5.02 (GraphPad Software Inc., San Diego, California, USA) was used for statistical analysis and graphing. BD Accuri V 1.0.264.21 (BD Accuri C6 Software Inc., Ann Arbor, USA) was used for flow cytometry graphing.
Results
General animal and laboratory data
Effect of APO on GNT-induced decrease in body weight of rats. The animals were weighed before and after the experiments. A severe body weight loss caused by GNT was observed when compared with the control group. Pretreatment with APO significantly (p < 0.05, n ¼ 8) attenuated the GNT-induced decrease in body weight, but the reduction in body weight still significantly from the control group (Table 1) .
Effect of APO on GNT-induced increase in kidney weight and RSI of rats. Table 1 shows a significant (p < 0.05, n ¼ 8) increase in the weight of kidney and RSI compared to the control group caused by GNT. Preinjection with APO significantly lowered the kidney weight and RSI when compared to GNT-treated group (Table 1) .
Effect of APO on GNT-induced increase in urine volume of rats. GNT caused a significant (p < 0.05, n ¼ 8) elevation in the 24-h urine volume indicating the presence of polyuria compared to the control group. The 24-h urine volume was significantly (p < 0.05, n ¼ 8) decreased in APO/GNT group when compared to GNT-treated rats (Table 1) .
Biochemical parameters
Effect of APO on GNT-induced change in kidney function in rats. A significant (p < 0.05, n ¼ 8) elevation in urine protein, serum BUN, and Cr compared to the control group was observed after 7 days of treatment with GNT. Moreover, GNT caused significant decrease in CCr and albumin. Preinjection with APO significantly (p < 0.05, n ¼ 8) ameliorated changes induced by GNT in CCr, serum Cr, BUN, and proteinuria. Conversely, treatment with APO for 14 days did not significantly reverse the reduction in serum albumin induced by GNT ( Table 2) .
Effect of APO on GNT-induced increase in serum LDH activity of rats. Figure 1 shows that GNT significantly (p < 0.05, n ¼ 8) increased LDH activity compared to control rats. Preinjection with APO in rats produced a significant decrease in LDH activity induced by GNT.
Effect of APO on GNT-induced change in kidney oxidative biomarkers in rats. The results in Figure 2 show that GNT significantly (p < 0.05, n ¼ 8) increased the malondialdehyde (MDA) levels (Figure 2 
Flow cytometry results
The data in Figure 4 show that GNT significantly (p < 0.05, n ¼ 4) increased the CD95 amount in kidney tissues compared to control rats. Conversely, there was a significant decrease (p < 0.05, n ¼ 4) in the amount of CD95 in rats that were pretreated with APO compared to the GNT group, but still significantly different from the control group. p < 0.05, significantly different from control using one-way ANOVA followed by Tukey -Kramer multiple comparisons post hoc test. c p < 0.05, significantly different from GNT group using one-way ANOVA followed by Tukey -Kramer multiple comparisons post hoc test. p < 0.05, significantly different from control using one-way ANOVA followed by Tukey -Kramer multiple comparisons post hoc test. c p < 0.05, significantly different from GNT group using one-way ANOVA followed by Tukey -Kramer multiple comparisons post hoc test. Figure 1 . Effect of APO on GNT-induced increase in serum LDH activity of rats. GNT (100 mg/kg, i.p.); APO (10 mg/kg, i.p.). Data are expressed as mean + SEM, n ¼ 8. *p < 0.05, significantly different from control using one-way ANOVA followed by Tukey-Kramer multiple comparisons post hoc test. APO: apocynin; GNT: gentamicin; LDH: lactate dehydrogenase; SEM: standard error of the mean; ANOVA: analysis of variance. $ p < 0.05, significantly different from GNT group.
Histopathological results
Effect of APO on GNT-induced changes in histopathological examination of kidney in rats. Histopathological investigation of the kidney using H&E (Â200) stain showed normal glomeruli and normal renal tubules with normal lining renal tubular epithelium ( Figure 5(a) ). Kidney of GNT-induced rats showed hypercellularity in mesangial cells and adhesion between parietal and visceral layers of Bowman's capsule (proliferative glomerulonephritis; arrow), with degeneration of renal tubular epithelium ( Figure 5(b) ). Animals treated with APO ( Figure 5(c) ) showed normal renal tubular epithelium lining renal tubules.
Discussion
This study is the first to show that APO could attenuate GNT-induced kidney dysfunction. In this study, APO has an ameliorative effect against nephrotoxicity induced by GNT as illustrated by decreasing GNTinduced elevation in kidney weight, RSI, serum Cr, BUN, proteinuria, LDH level, kidney MDA, NO level, and CD95 amount, in addition to normalizing CCr and improving kidney histopathological changes in rats.
GNT is a member of aminoglycoside antibiotics; nephrotoxicity as a side effect of all aminoglycosides, especially GNT, limits its therapeutic use. 2 In the present study, GNT injection for 1 week caused a significant reduction in body weight of rats and a significant increase in the RSI and in the weight of kidney compared to control rats. This loss in weight may be due to either direct injury in renal tubules resulting in inability of the tubular cells to reabsorb water, leading to dehydration and loss of body weight 31 or increased catabolism resulting in acidosis, anorexia, and decreased food intake. 32 The increase in kidney weight after GNT injection is a result of inflammation and edema. 33 The weight loss and the increase in kidney weight were also observed in previous studies. 34, 35 APO administration significantly decreased the kidney weight and RSI when compared to the GNTtreated rats; this result may be due to APO's antiinflammatory effect by reducing the inflammatory cytokines, such as TNF-a, IL-1, and IL-6. 12 GNT induced a typical pattern of nephrotoxicity that was associated with significant increase in serum Cr, BUN levels, and a higher volume of urine and protein. During renal dysfunction and as a result of diminished glomerular filtration rate, there is a reduction of the kidney's ability to filter Cr and the nonprotein waste product is produced. Moreover, during renal dysfunction, the levels of urea and uric acid are elevated, 36 and protein level in urine is increased which might be a sensitive indicator of tubular damage, impaired reabsorptive capability of tubular protein, or impaired protein filtration of glomerular barrier. 37 The results of this study show that intraperitoneal injections of GNT to Wistar rats induced nephrotoxicity which was manifested by elevation in serum urea and Cr levels indicating glomerular damage. Additionally, a reduction in GFR is produced by GNT, clarified by the reduction in CCr and elevated levels of urine protein indicating tubular damage. These results came in line with other studies. 34, 38, 39 APO has a very good safety profile in animal studies as well, and several studies used long-term treatment without any signs of ill-health effects. Previous studies reported that the renal function and the morphology of normal kidney were not altered by the administration of APO in normal rats, APO was given in the drinking water (2 g/L) 41 or injected in dose of (20 mg/kg, i.p.) in rats. 42 APO produced a significant reduction in serum Cr and BUN level, and normalizing CCr. The ameliorative effect of APO on the kidney markers may be attributed to the protection against oxidative injury. These findings are in line with Chirino et al. who showed that administration of APO in the drinking water (2 g/L) 7 days before and 3 days after cisplatin injection ameliorates the increased serum Cr, BUN, and urinary excretion of total protein induced by cisplatin. 41 In addition, Altintas et al. stated that APO (20 mg/kg, i.p., before ischemia and during ischemia) has a protective effect against renal ischemia/reperfusion (I/R)-induced kidney damage by significantly decreasing the elevated BUN and Cr levels. 42 Treatment with GNT has been shown to involve renal inflammatory responses in experimental animals. [43] [44] [45] In the present study, GNT caused a significant elevation in serum LDH, with a significant decrease in the level of albumin in serum; this result agrees with El-Kashef et al. 7 Treatment of rats with APO attenuated the elevation of serum LDH induced by GNT; this may be due to the anti-inflammatory properties of APO.
The components of NOX in the kidney are expressed in the glomerular mesangial, renal vessels, macula densa, distal tubule, the thick ascending limb, and collecting ducts. 46 NOX are the major source of ROS in many tissues that play both physiological and pathophysiological roles. 47 Due to the sensitivity of urinary system toward oxidative stress, ROS play an important role in the pathogenesis of drug-induced kidney diseases. [48] [49] [50] Oxidative stress has participated in nephrotoxicity; ROS is the central key in the mechanisms that lead to a decrease in glomerular filtration rate and tubular necrosis. 51 Another mechanism of GNT-induced nephrotoxicity is oxidative stress. GNT exerts its adverse renal toxicity by the generation of ROS in the kidney such as superoxide anions, 52 hydrogen peroxide, hydroxyl radicals, and reactive nitrogen species (RNS). 53 Interaction of excessively produced ROS with cellular components, such as lipids (peroxidation of unsaturated fatty acids in the cell membrane), proteins (denaturation), carbohydrates, and nucleic acids resulted in cell and tissue damage. 54 GNT-induced tissue damage may be due to the depletion of renal GSH which permits lipid peroxidation. 55 Therefore, ROS scavengers and antioxidant molecules have the capacity to partially reduce or eliminate the deleterious effects induced by GNT. In the current study, one of the causes of GNTinduced renal damage is oxidative stress. This view is supported by a significant elevation in the renal tissue levels of MDA as reflected by an increase in TBARS which is an end product of lipid peroxidation, while kidney antioxidant enzymes like SOD and GSH levels were reduced in the kidney tissue. The same observations were also showed in other studies. 7, 56 APO by its NOX inhibition activity showed a significant reduction in the level of MDA and prevented the reduction in SOD activity compared to rats treated with GNT. The mechanism of inhibition of NOX is not totally known but involves inhibition of NOX component expressions such as p67-phox, p47-phox, and gp91-phox. 18 These results are in line with other studies that demonstrated that APO prevents the generation of oxidative stress in the kidney after cisplatin-induced nephrotoxicity, 41 cyclosporine-induced nephrotoxicity, 16 renal I/R injury, 57 and after streptozotocin-induced diabetic nephropathy. 15 Additionally, APO prevents the elevation of oxidative stress in the lung after LPS 11 and after bleomycin. 58 The protective effect of APO might be due to the reduction of the free radicals induced by GNT.
NO plays an important role in pathological and physiological pathways in the kidney. NO is important in the renal tubular function regulation and renal hemodynamics regulation. 59 Narita et al. 60 reported that decreased glomerulosclerosis and glomerular injury was produced by limiting NO production. In the kidney, GNT induced increase in the level of NO; the free radical nature of NO has a role in the acute renal failure caused by GNT leading to tubular damage. 61, 62 In addition, NO reacts with superoxide radical and generates a cytotoxic peroxynitrite, resulting in renal failure and damage of the tubular cells. 3 In this study, GNT caused a significant increase in NO level; this result agrees with El-Kashef et al. 7 APO, by its NOX inhibition, significantly decreases the high level of NO induced by GNT injection. This result is in agreement with the other study reported that APO significantly reduced the activity of inducible nitric oxide synthase (iNOS) in renal tissues compared to the renal (I/R) injury group. 57 In addition to oxidative stress, one of the main side effects of GNT is in vivo and in vitro apoptosis in mesangial and proximal tubule cells. The ROS pathway is known to be important mediators in apoptosis induced by GNT. 45 GNT-induced apoptosis is associated with an increase in the proapoptotic protein Bax, in the survival promoting protein Bcl-2, 63 and in CD95.
64 CD95 (APO-1/Fas) is a member of the death receptor family, a subfamily of the tumor necrosis factor receptor (TNF-R) superfamily. Its main and best-known function in signaling is the induction of apoptosis. Within seconds after CD95 stimulation, the death-inducing signaling complex is formed. 65 In this study, Fas and Fas ligand were detected as a marker of apoptosis, which was detected by CD95. GNT caused a significant increase in CD95 amount which may be due to increased production of ROS; this result is in line with Asmaa et al. 64 APO significantly reduced the high amount of CD95 induced by GNT injection. This result may be explained by the antioxidant and antiapoptotic properties of APO. This result is in agreement with the other study which reported that APO, by its anti-apoptotic effect, protects against apoptosis in renal (I/R) injury 42 and in diabetic nephropathy. 66 The histological investigation of kidneys from rats injected with GNT showed hypercellularity in mesangial cells and adhesion between parietal and visceral layers of Bowman's capsule (proliferative glomerulonephritis), with degeneration of renal tubular epithelium. Animals treated with APO for 14 days showed normal renal tubular epithelium lining renal tubules, establishing its protective effect against tissue damage induced by GNT.
In conclusion, this is the first study reported that APO protects rats from nephrotoxicity induced by GNT by exerting antioxidant, antiapoptotic, and anti-inflammatory properties. This was supported by biochemical measurements and histopathological examination. Therefore, APO represents a new therapy for GNT-induced nephrotoxicity; however, more investigation is needed to determine its precise mechanism of action.
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